Drug General Information (ID: DDIQ5RS4OI)
  Drug Name Rituximab Drug Info Chloramphenicol (ophthalmic) Drug Info
  Drug Type Monoclonal antibody Small molecule
  Therapeutic Class Antineoplastics Antibiotics

 Mechanism of Rituximab-Chloramphenicol (ophthalmic) Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Rituximab Chloramphenicol (ophthalmic)
      Mechanism Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Rituximab and Chloramphenicol (ophthalmic) 

Recommended Action
      Management Concurrent use of chloramphenicol with other bone marrow depressing agents should be avoided.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Sim SM, Back DJ, Breckenridge AM "The effect of various drugs on the glucuronidation of zidovudine (azidothymidine AZT) by human liver microsomes." Br J Clin Pharmacol 32 (1991): 17-21. [PMID: 1909542]